Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Beta-1a nasal spray in hospitalized COVID-19 patients
IRCT20200511047396N1Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Jun 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of interferon beta-1a in coronavirus disease 2019 (COVID-19), sponsored by CinnaGen. Started Jun 2020; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200511047396N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200511047396N1.